Trilaciclib hydrochloride

≥99%

  • Product Code: 103029
  CAS:    1977495-97-8
Molecular Weight: 519.47 g./mol Molecular Formula: C₂₄H₃₂Cl₂N₈O
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: Trilaciclib hydrochloride is primarily used in the treatment of small cell lung cancer (SCLC). It is administered intravenously to patients undergoing chemotherapy to protect bone marrow cells from damage. By inhibiting cyclin-dependent kinase 4/6 (CDK4/6), it helps reduce chemotherapy-induced myelosuppression, a condition where bone marrow activity is decreased, leading to lower production of blood cells. This application helps in maintaining healthier blood cell counts, reducing the need for interventions like blood transfusions or growth factor support, and improving overall patient tolerance to chemotherapy.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days $809.57
+
-
0.005 10-20 days $2,343.48
+
-
Trilaciclib hydrochloride
Trilaciclib hydrochloride is primarily used in the treatment of small cell lung cancer (SCLC). It is administered intravenously to patients undergoing chemotherapy to protect bone marrow cells from damage. By inhibiting cyclin-dependent kinase 4/6 (CDK4/6), it helps reduce chemotherapy-induced myelosuppression, a condition where bone marrow activity is decreased, leading to lower production of blood cells. This application helps in maintaining healthier blood cell counts, reducing the need for interventions like blood transfusions or growth factor support, and improving overall patient tolerance to chemotherapy.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: $0.00
$0.00 Total :